top of page

Publications

Original Article

Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors

Measuring Human Immunity

2007

Authors:

Ghanekar SA, Bhatia S, Ruitenberg JJ, delaRosa C, Disis ML, Maino VC, Maeker HT and Waters CA

Journal:

Journal of Immune Based Therapies and Vaccines

Volume:

5

Page:

7

Review Article

Adoptive T cell therapy of solid cancers

Tumor Microenvironment

2006

Authors:

Knutson KL, Wagner W and Disis ML

Journal:

Immunology Immunotherapy

Volume:

55(1)

Page:

96-103

Original Article

The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens

Tumor Microenvironment

2006

Authors:

Lu H, Knutson KL, Gad E, Disis ML

Journal:

Cancer Research

Volume:

66(19)

Page:

9754-61

Review Article

Laboratory analysis of T-cell immunity

T Cell Function & Therapy

2006

Authors:

Knutson KL, dela Rosa C, and Disis ML

Journal:

Frontiers in Bioscience

Volume:

11

Page:

1932-44

Review Article

Progress in ovarian cancer research: Proceedings
of the 5th Biennial Ovarian Cancer Research
Symposium

2006

Authors:

Disis ML, Rivkin SE, Baron A, Markman M, Connolly D, Ueland F, Kohne, Trimble E, Berek JS

Journal:

International Journal od Gynecological Cancer

Volume:

16(2)

Page:

463-9

Review Article

10th Biennial Helene Harris Memorial Trust Meeting

2006

Authors:

Balkwill FR, Ashworth A, Bast RC, Berek J, Boyd J, Disis ML, Gabra H, Gore ME, Hamilton TC, Jacobs IJ, Kaye SB, Kohn EC, Mills GB, and Urban ND

Journal:

Cancer Research

Volume:

66(6)

Page:

2904-6

Original Article

Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1

Cancer Vaccines

2006

Authors:

Wang W, Epler J, Salazar LG, and Riddell SR

Journal:

Cancer Research

Volume:

66(13)

Page:

6826-33

Original Article

Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals"

Tumor Microenvironment

2006

Authors:

Manjili MH, Arnouk H, Knutson KL, Kmieciak M, Disis ML, Subjeck JR and Kazim AL

Journal:

Breast Cancer Research and Treatment

Volume:

96(3)

Page:

243

Original Article

IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice

Cancer Vaccines

2006

Authors:

Knutson KL, Dang Y, Lu H, Lukas J, Almand B, Gad E, Azeke E, and Disis ML

Journal:

Journal of Immunology

Volume:

177(1)

Page:

84-91

Original Article

Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain

General Immune Research

2006

Authors:

Thompson JA, Dissanayake SK, Ksander BR, Knutson KL, Disis ML, and Ostrand-Rosenberg S

Journal:

Cancer Research

Volume:

66(2)

Page:

1147-54

bottom of page